Export 7 results:
Author Title [ Type(Desc)] Year
Filters: Author is Belshe, Robert  [Clear All Filters]
Journal Article
R. W. Frenck, Belshe, R., Brady, R. C., Winokur, P. L., Campbell, J. D., Treanor, J., Hay, C. M., Dekker, C. L., Walter, E. B., Cate, T. R., Edwards, K. M., Hill, H., Wolff, M., Leduc, T., and Tornieporth, N., Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults., Vaccine, vol. 29, no. 34, pp. 5666-74, 2011.
J. E. Ledgerwood, Bellamy, A. R., Belshe, R., Bernstein, D. I., Edupuganti, S., Patel, S. M., Renehan, P., Zajdowicz, T., Schwartz, R., Koup, R., Bailer, R. T., Yamshchikov, G. V., Enama, M. E., Sarwar, U., Larkin, B., and Graham, B. S., DNA priming for seasonal influenza vaccine: a phase 1b double-blind randomized clinical trial., PLoS One, vol. 10, no. 5, p. e0125914, 2015.
M. Laassri, Lottenbach, K., Belshe, R., Wolff, M., Rennels, M., Plotkin, S., and Chumakov, K., Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains., J Infect Dis, vol. 192, no. 12, pp. 2092-8, 2005.
D. I. Bernstein, Edwards, K. M., Dekker, C. L., Belshe, R., Talbot, H. K. B., Graham, I. L., Noah, D. L., He, F., and Hill, H., Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults., J Infect Dis, vol. 197, no. 5, pp. 667-75, 2008.
J. Treanor, Keitel, W., Belshe, R., Campbell, J., Schiff, G., Zangwill, K., Wolff, M., Klimov, A., Levandowski, R., and Lambert, L., Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults., Vaccine, vol. 20, no. 7-8, pp. 1099-105, 2002.
R. C. Brady, Treanor, J. J., Atmar, R. L., Keitel, W. A., Edelman, R., Chen, W. H., Winokur, P., Belshe, R., Graham, I. L., Noah, D. Lee, Guo, K., and Hill, H., Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults., Vaccine, vol. 27, no. 37, pp. 5091-5, 2009.
C. Carter, Houser, K. V., Yamshchikov, G. V., Bellamy, A. R., May, J., Enama, M. E., Sarwar, U., Larkin, B., Bailer, R. T., Koup, R., Chen, G. L., Patel, S. M., Winokur, P., Belshe, R., Dekker, C. L., Graham, B. S., and Ledgerwood, J. E., Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial., PLoS One, vol. 14, no. 9, p. e0222178, 2019.